The total return over the past 12 months is +35.12% vs. +19.51% for the S&P 500. So far it's up +2.75% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | +35.12% | +31.60% | +26.81% | N/A | N/A | N/A |
| Total Return CAGR | +35.12% | +31.60% | +26.81% | N/A | N/A | N/A |
| Revenue CAGR | +24.67% | +18.48% | +22.03% | +21.60% | N/A | N/A |
| Net Income CAGR | +17.50% | +22.30% | +22.87% | +27.33% | N/A | N/A |
| EPS CAGR | +19.77% | +27.36% | +30.90% | +22.80% | N/A | N/A |
| Free Cash Flow CAGR | +26.51% | +25.23% | +23.40% | +26.70% | N/A | N/A |
| Operating Cash Flow CAGR | +22.56% | +22.66% | +21.41% | +25.39% | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Medpace Holdings, Inc. (MEDP)
| Year | Start price | End price | MEDP Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $561.65 | $577.11 | +2.75% | +10.13% | (7.38%) |
| 2025 | $332.23 | $561.65 | +69.05% | +17.72% | +51.33% |
| 2024 | $306.53 | $332.23 | +8.38% | +24.89% | (16.51%) |
| 2023 | $212.41 | $306.53 | +44.31% | +26.19% | +18.12% |
| 2022 | $217.64 | $212.41 | (2.40%) | (18.17%) | +15.77% |
| 2021 | $139.20 | $217.64 | +56.35% | +28.74% | +27.61% |
| 2020 | $84.06 | $139.20 | +65.60% | +18.37% | +47.23% |
| 2019 | $52.93 | $84.06 | +58.81% | +31.22% | +27.59% |
| 2018 | $36.26 | $52.93 | +45.97% | (4.56%) | +50.53% |
| 2017 | $36.07 | $36.26 | +0.53% | +21.70% | (21.17%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
